Field dossier · from the corpus
Recombinant DNA
1predicted collisions
Where this field is predicted to collide
Most cited work
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
Strategies for optimization of heterologous protein expression in E. coli: Roadblocks and reinforcements
Cloaking nanoparticles with protein corona shield for targeted drug delivery
Recent work · 2024 onward
Novel chemical tyrosine functionalization of adeno-associated virus improves gene transfer efficiency in liver and retina
Anticodon-edited transfer RNAs (ACE-tRNAs) encoded as therapeutic nonviral minimal DNA vectors
Optimizing laboratory practices for recombinant adeno-associated viral vectors: impact of stress factors on vector stability
Metadata assessment of non-human primate studies of AAV9 uncovers potential tissue specific variation in expression efficiency
The Template-Jumping Editing Approach in F9-Associated Hemophilia B Gene Therapy
Simultaneous detection of the AAV genomes and their transcripts in situ at the single-cell level